Biocon Limited, an innovation-led global biopharmaceuticals company, announced that Dr. Sriram AV, Head – Quality will superannuate on October 31, 2023. Nitin Tiwari has been appointed to the role of Head -Quality of the company, with effect from November 1, 2023. Nitin Tiwari holds a master’s degree in fine chemicals and drugs from G.S. Institute…
Biocon Ltd., an innovation-led global biopharmaceuticals company, announced, that its Board has approved the appointment of Peter Bains as the Group CEO, with effect from September 18th, 2023. He will be reporting directly to Biocon Group Chairperson, Kiran Mazumdar-Shaw. Bains has accordingly stepped down from his role on the Biocon Board as an Independent Director with…
Biocon Limited announced the appointment of Rekha Mehrotra Menon as Additional Director on the company’s Board, with effect from July 26, 2023. According to the company’s exchange filing, “we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company vide Circular Resolution dated…
Pharmaceutical company Biocon has appointed Maninder Kapoor Puri as the Head of Human Resources. Maninder Kapoor Puri joined Biocon Limited in June 2023 as the Head of Human Resources for the company’s Generics Business and Biocon Academy. Maninder joined Biocon from Mastek Group where she was Global Chief Human Resources and Diversity Officer. In her…
Biocon Biologics Limited, the biosimilar arm of Biocon, announced the appointment of Stephanie Wasco as Head of Communications – Advanced Markets. Stephanie is an accomplished corporate communications and marketing leader, as well as a strategist, innovative thinker and change agent. She brings with her over 25 years of experience developing and executing robust external and…
Biocon Limited announced the appointment of Peter Bains as Independent Director on the company’s Board, with effect from December 12, 2022. According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, (‘SEBI Listing Regulations’) and in continuation to our letter dated November 14, 2022, wherein it…
Cyril Amarchand Mangaldas advised Biocon Limited (Biocon), in relation to the sale of shares by Biocon Limited in Syngene International Limited (Syngene International), by way of a bulk trade on the stock exchanges, aggregating to INR 1220.28 crores. The Capital Market Practice of Cyril Amarchand Mangaldas advised Biocon for the transaction and assisted with, reviewing, and finalizing the transaction…
Biocon Foundation, the CSR (corporate social responsibility) arm of the Bengaluru-headquartered Biocon Limited, has been conferred with the ‘Mahatma Award 2022 For Excellence in Social Good’. The awards were presented on the eve of the Birth Anniversary of the Father of the Nation Mahatma Gandhi in New Delhi. Mahatma Awards were founded and instituted by…
Biotechnology major Biocon Limited has appointed Naina Lal Kidwai as Non-Executive and Independent Director on the company’s Board, with effect from April 28, 2022. According to the company’s exchange filing, “Approved the appointment of Ms. Naina Lal Kidwai (DIN: 00017806) as an Additional Director (Category: Non-Executive and Independent Director) of the Company with effect from…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment by Abu Dhabi based ADQ, one of the region’s largest holding companies. As per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80% minority stake in…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that it has ranked among the Top 5 Global Biotech Employers for 2020 on the U.S.-based Science magazine’s annual ‘Science Careers Top 20 Employers’ list. Ranked at No. 5 among global pharma and biotech companies in 2020, Biocon has moved up steadily from No. 7 in 2018…
The Executive Chairperson of Biocon, Kiran Mazumdar Shaw recently through social media platform Twitter announced that she has tested positive for the novel coronavirus. In her tweet informing the people of her health, the 67-year old biotech industry veteran said, “I have added to the COVID count by testing positive. Mild symptoms n I hope…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that the Board of its subsidiary Biocon Biologics India Limited (Biocon Biologics) has approved a primary equity investment by Tata Capital Growth Fund. As per the terms of the proposed agreement, Tata Capital will invest Rs 225 Crore for a 0.85% minority stake in the biosimilar business,…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19. Itolizumab is…
Biocon Ltd, an innovation-led global biopharmaceutical company, and DKSH, a leading market expansion services provider with a focus on Asia, announced that Biocon’s subsidiary, Biocon Pharma Limited and DKSH Business Unit Healthcare, have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma’s generic formulations in Singapore and Thailand. Under the…